DOV vs TRVI · P/E 27, rev $4.24B vs $2.32B cap
Dover Corporation (DOV) versus Trevi Therapeutics Inc (TRVI) — a side-by-side from cached financials, not a winner call.
Dover Corporation (DOV) is a specialty industrial machinery company listed on US.
Trevi Therapeutics Inc (TRVI) is a biotechnology company listed on NASDAQ.
Latest reported DOV revenue for 2026-06-30 was $4.24B. Net income was $550.7M. DOV currently screens at market cap $28.92B and trailing P/E 26.8.
TRVI does not have a complete income-statement cache yet.
DOV currently screens at market cap $28.92B and trailing P/E 26.8. TRVI currently screens at market cap $2.32B.
Not investment advice. Open the DOV and TRVI stock pages for the full models.
Not investment advice.